South Africa
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
22.16%
|
June 30, 2024 | USD 9.35 | 3.39% |
|
South Africa |
|
2 |
17.33%
|
Sept. 30, 2024 | USD 0.82 | -1.03% |
|
South Africa |
|
3 |
14.76%
|
June 30, 2024 | USD 3.52 | 1.00% |
|
South Africa |
|
4 |
7.47%
|
June 30, 2024 | USD 0.04 | 1.93% |
|
South Africa |
|
5 |
7.33%
|
June 30, 2024 | USD 0.09 | 0.67% |
|
South Africa |
|
6 |
-9.62%
|
Aug. 31, 2024 | USD 0.02 | -19.59% |
|
South Africa |
The Pharmaceuticals company in South Africa with the highest EBITDA Margin is Aspen Pharmacare Holdings Limited (Johannesburg Stock Exchange: APN.JO) at 22.16%.
The Pharmaceuticals company in South Africa with the lowest EBITDA Margin is AYO Technology Solutions Limited (Johannesburg Stock Exchange: AYO.JO) at -9.62%.
The top 10 Pharmaceuticals companies in South Africa by EBITDA Margin are Aspen Pharmacare Holdings Limited, Life Healthcare Group Holdings Limited, Adcock Ingram Holdings Limited, Ascendis Health Limited, AfroCentric Investment Corporation Limited and AYO Technology Solutions Limited.
The bottom 10 Pharmaceuticals companies in South Africa by EBITDA Margin are AYO Technology Solutions Limited, AfroCentric Investment Corporation Limited, Ascendis Health Limited, Adcock Ingram Holdings Limited, Life Healthcare Group Holdings Limited and Aspen Pharmacare Holdings Limited.